Ferozsons Laboratories Limited reported a net profit of Rs 650.90 million for the year ended 30 June 2026
Filed as: Financial Results for the Year Ended 2026-06-30
Summary
Ferozsons Laboratories Limited reported a net profit of Rs 650.90 million for the year ended 30 June 2026, up from Rs 528.24 million in the prior year. Revenue increased to Rs 15.76 billion, reflecting strong sales growth.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | PKR 15.76 billion | PKR 13.86 billion | +13.7% |
| Net Profit | PKR 650.90 million | PKR 528.24 million | +23.2% |
| Earnings Per Share | PKR 14.97 | PKR 12.15 | +23.2% |
| Gross Profit | PKR 6.63 billion | PKR 5.72 billion | +15.9% |
| Operating Profit | PKR 1.39 billion | PKR 1.38 billion | +1.1% |
| Cash and Cash Equivalents | PKR 361.12 million | PKR 345.58 million | +4.5% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue increased by 13.71% to Rs 15.76 billion from Rs 13.86 billion in the prior year.
- Net profit rose by 23.22% to Rs 650.90 million, indicating improved profitability.
- Earnings per share increased to Rs 14.97 from Rs 12.15, reflecting enhanced shareholder value.
Ferozsons Laboratories Limited (FEROZ) on Nafa
Last price Rs 364.02 · Pharmaceuticals · You can own FEROZ shares from your phone.
More FEROZ announcements
- NoticeCredit of final cash dividend
- NoticeChange of Company Secretary
- NoticeCompany Secretary
- NoticeTransmission of Quarterly Financial Statements for the Period Ended 30-09-2026
- Financial resultFerozsons Laboratories Limited reported a strong performance for the first quarter ended 30 September 2026Filed as: Financial Results for the Quarter Ended 30-09-2026
- NoticeCertified True Copies of the Resolutions passed at the 70th Annual General Meeting of the Company
Source: Ferozsons Laboratories Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.